16:05 EST Immunome (IMNM) files to sell 1.8M shares of common stock for holders Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended by analysts >> Read More on IMNM: Immunome price target lowered to $21 from $23 at Piper Sandler Immunome, Inc. Reports Q3 2024 Financial Results Immunome reports Q3 EPS (78c), consensus (56c) IMNM Earnings this Week: How Will it Perform? Molson Coors upgraded, Rivian downgraded: Wall Street’s top analyst calls Disclaimer & DisclosureReport an Issue
